Latest Articles
Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients - Stock Titan
Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients Stock Titan
Published: May 14, 2025, 8:10 p.m.
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer - Healio
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer Healio
Published: May 14, 2025, 8:04 p.m.
Bindi Irwin Undergoes 14 Endometriosis Lesions Excised, and Other Surgeries: Can Endometriosis Lesions Be Cancerous? - MSN
Bindi Irwin Undergoes 14 Endometriosis Lesions Excised, and Other Surgeries: Can Endometriosis Lesions Be Cancerous? MSN
Published: May 14, 2025, 6:01 p.m.
The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021 - BMC Public Health
The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021 BMC Public Health
Published: May 14, 2025, 5:32 a.m.
Bindi Irwin Undergoes 14 Endometriosis Lesions Excised, and Other Surgeries: Can Endometriosis Lesions Be Cancerous? - OnlyMyHealth
Bindi Irwin Undergoes 14 Endometriosis Lesions Excised, and Other Surgeries: Can Endometriosis Lesions Be Cancerous? OnlyMyHealth
Published: May 13, 2025, 8:52 a.m.
Early-Onset Breast, Colorectal, Endometrial, Pancreatic, and Kidney Cancers on the Rise - The ASCO Post
Early-Onset Breast, Colorectal, Endometrial, Pancreatic, and Kidney Cancers on the Rise The ASCO Post
Published: May 12, 2025, 2:24 p.m.
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer - OncLive
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer OncLive
Published: May 12, 2025, 12:39 p.m.
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 - openPR.com
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 openPR.com
Published: May 12, 2025, 10:53 a.m.
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature
Published: May 10, 2025, 10:19 a.m.
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer - OncLive
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer OncLive
Published: May 9, 2025, 11:26 p.m.
Link copied to clipboard!